Plenary II Session

This session will review the latest science in the field of radiopharmaceutical therapy.

Target Audience

This meeting was designed to meet the interests of medical oncologists, radiation oncologists, physicists, nurses, diagnostic radiologists,  radiation therapists, radiation dosimetrists, specialists, nuclear physicians and practice administrators. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify the latest science in the field of radiopharmaceutical therapy.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.
Course opens: 
03/02/2026
Course expires: 
03/01/2028
Cost:
$0.00
Part of: 
2026 Multidisciplinary Radiopharmaceutical Therapy Symposium onDemand
Rating: 
0

Speakers

  • Robert Hobbs, PhD, DABR, Johns Hopkins University 
  • Terence M. Williams, MD, PhD, City of Hope 
  • Siju George, PhD, Herbert Wertheim College of Medicine, Florida International University, Miami
  • Sean Maroongroge, MD, MBA, Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA
  • Serguei Castaneda, MD, CB Oncology Partners, Cutler Bay, FL
  • Seema Kacker, MD, PhD, Johns Hopkins University School of Medicine, Baltimore
  • Dustin Boothe, MD, Intermountain Health, Salt Lake City
  • Jose Garcia-Ramirez, MS, WashU Medicine, Department of Radiation Oncology, St. Louis
  • Ranjini Tolakanahalli, PhD, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami
  • Daniel Sforza, PhD, Department of Radiation Oncology and Molecular Radiation Sciences, School of Medicine, Johns Hopkins University, Baltimore Radiopharmaceutical Retreatment
  • Andrew Salner, MD, FASTRO, Hartford HealthCare Cancer Institute, Hartford, CT

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.